prikaz prve stranice dokumenta Analysis of the frequency of EGFR, KRAS and ALK mutations in patients with lung adenocarcinoma in Croatia
  Download
PDF 425.92 KB
Scientific paper - Original scientific paper
Analysis of the frequency of EGFR, KRAS and ALK mutations in patients with lung adenocarcinoma in Croatia
Diagnostic Pathology, 11 (2016), 1; 90. https://doi.org/10.1186/s13000-016-0544-9
Brčić, Luka; Jakopović, Marko; Mišić, Marija; Seiwerth, Fran; Kern, Izidor; Smojver-Ježek, Silvana; Quehenberger, Franz; Samaržija, Miroslav; Seiwerth, Sven

Cite this document

Brčić, L., Jakopović, M., Mišić, M., Seiwerth, F., Kern, I., Smojver Ježek, S. ... Seiwerth, S. (2016). Analysis of the frequency of EGFR, KRAS and ALK mutations in patients with lung adenocarcinoma in Croatia. Diagnostic Pathology, 11. (1), 90. doi: 10.1186/s13000-016-0544-9

Brčić, Luka, et al. "Analysis of the frequency of EGFR, KRAS and ALK mutations in patients with lung adenocarcinoma in Croatia." Diagnostic Pathology, vol. 11, no. 1, 2016, p. 90. https://doi.org/10.1186/s13000-016-0544-9

Brčić, Luka, Marko Jakopović, Marija Mišić, Fran Seiwerth, Izidor Kern, Silvana Smojver Ježek, Franz Quehenberger, Miroslav Samaržija and Sven Seiwerth. "Analysis of the frequency of EGFR, KRAS and ALK mutations in patients with lung adenocarcinoma in Croatia." Diagnostic Pathology 11, no. 1 (2016): 90. https://doi.org/10.1186/s13000-016-0544-9

Brčić, L., et al. (2016) 'Analysis of the frequency of EGFR, KRAS and ALK mutations in patients with lung adenocarcinoma in Croatia', Diagnostic Pathology, 11(1), p. 90. doi: 10.1186/s13000-016-0544-9

Brčić L, Jakopović M, Mišić M, Seiwerth F, Kern I, Smojver Ježek S, and sur.. Analysis of the frequency of EGFR, KRAS and ALK mutations in patients with lung adenocarcinoma in Croatia. Diagnostic Pathology [Internet]. 2016 September 21 [cited 2024 December 31];11(1):90. doi: 10.1186/s13000-016-0544-9

L. Brčić, et al., "Analysis of the frequency of EGFR, KRAS and ALK mutations in patients with lung adenocarcinoma in Croatia", Diagnostic Pathology, vol. 11, no. 1, p. 90, September 2016. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:258965. [Accessed: 31 December 2024]

Please login to the repository to save this object to your list.
Metadata
Title (english)Analysis of the frequency of EGFR, KRAS and ALK mutations in patients with lung adenocarcinoma in Croatia
AuthorLuka Brčić
AuthorMarko Jakopović
AuthorMarija Mišić
AuthorFran Seiwerth
AuthorIzidor Kern
AuthorSilvana Smojver-Ježek
AuthorFranz Quehenberger
AuthorMiroslav Samaržija
AuthorSven Seiwerth
Author's institutionUniversity of Zagreb
School of Medicine
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Abstract (english)
BACKGROUND: Many studies have been published on the mutational status of patients with lung adenocarcinomas, and great population-based variability in mutation frequencies has been reported. The main objective of the present study was to analyze the EGFR, KRAS and ALK mutation status in a representative cohort of patients in Croatia with lung adenocarcinomas and to correlate the mutational status with clinical data. ----- METHODS: All patients who were newly diagnosed within 6 months with histologically proven primary lung adenocarcinomas were included. Mutational analyses for EGFR and KRAS mutations were performed in a cobas z 480 analyzer. ALK immunohistochemistry was performed using the D5F3 clone on Benchmark XT instrument. Clinical data were obtained from the medical records. ----- RESULTS: Of the 324 patients, 59.9 % were male. At the time of diagnosis, the patients ranged in age range from 35 to 88 years (median 63 years). Most of the patients were current smokers or former smokers (77.2 %). EGFR mutations were found in 15.7 % of the patients, and of these mutations, exon 19 deletion was the most common (45.1 %). KRAS mutations were present in 34.9 % of the patients, while 4.1 % of patients were ALK-positive. The statistical significance of the presence of mutations was detected for both gender and smoking. ----- CONCLUSION: The detected mutation rates demonstrated a slightly higher prevalence of KRAS mutations, but not a higher prevalence of EGFR mutations or ALK gene rearrangement, in comparison with the rates found in other European countries. EGFR and ALK mutational status showed a statistically significant correlation with gender as well as with smoking, while KRAS mutation status showed a statistically significant correlation only with smoking.
Languageenglish
Publication typeScientific paper - Original scientific paper
Publication statusPublished
Peer reviewPeer review
Publication versionAccepted version
Journal titleDiagnostic Pathology
Numberingvol. 11, no. 1, p. 90
p-ISSN1746-1596
DOIhttps://doi.org/10.1186/s13000-016-0544-9
URN:NBNurn:nbn:hr:105:258965
Publication2016-09-21
Document URLhttps://doi.org/10.1186/s13000-016-0544-9
Type of resourceText
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2024-03-28 08:46:47